Page results
-
Among the many cancer clinical trials opening each year at UCLH, this year will see a focus on trials of personalised cancer treatments based on precision immunotherapies.
-
UCLH is continuing to scale up the number of services that offer Advice & Guidance, as well as identifying various improvements within the existing Advice & Guidance service. Over the last few months, UCLH has introduced 5 new specialties to the service, with additional specialties due to go live shortly.
-
Our staff have rated UCLH as the top trust in England, improving on our ranking from last year when we were third best in England and top in London.
-
The NHS has become the first healthcare system in the world to provide a new blood group genotyping test which is set to transform care for patients living with sickle cell disorder and thalassaemia.
-
UCLH has recruited the first patient in Europe for an early phase trial of a potential new medicine for patients that have a specific sub-type of multiple myeloma (MM), a type of bone marrow cancer.
-
Information about preparing for and undergoing surgery at University College London Hospitals NHS Foundation Trust.
-
Read more about a UCLH patient saved by special 'before midnight' transfusions.
-
Nine Covid-19 research studies are already taking place at UCLH and the Trust is processing more than 30 study proposals as research efforts around the virus and pandemic are ramped up.
-
Information about our UCLH Charity, charity funds and associated charities.
-
UCLH is the first NHS trust to pilot a personalised educational package for patients living with stroke.
File results
-
FOI/2021/0447 - IT solutions used at the Trust
-
FOI/2021/0449 - Treatment of spasticity
-
FOI/2021/0451 - Vaccinated/ unvaccinated patients
-
FOI/2021/0453 - Private security company providing security officers
-
FOI/2021/0457 - International staff
-
FOI/2021/0458 - Breathing filters used in mechanical ventilators for (COVID-19) patients
-
FOI/2021/0463 - Staff accommodation
-
FOI/2021/0466 - Patient wait of more than 52 weeks for elective treatment
-
FOI/2021/0467 - Celebration of Pride in 2020 and 2021
-
FOI/2021/0468 - Patient data management system